Skip to content

Home
Stock Stories
US Equities
Ticker Update
Equity Analysis

Menu

Home
Stock Stories
US Equities
Ticker Update
Equity Analysis

NASDAQ:FOLD

Tag
NASDAQ:FOLD

Finance

Amicus Therapeutics Inc. [FOLD] stock Resumed by BTIG Research analyst, price target now $15

Edison Baldwin July 23, 2021

Companies

Amicus Therapeutics Inc. [FOLD] moved down -4.37: Why It’s Important

Annabelle Farmer July 13, 2021

Industry

Wall Street Analyst Initiated Amicus Therapeutics Inc. [FOLD]. What else is Wall St. saying

Misty Lee July 9, 2021

Finance

Amicus Therapeutics Inc. [FOLD] Stock trading around $9.88 per share: What’s Next?

Caleb Clifford July 2, 2021

Finance

Wall Street Analyst Initiated Amicus Therapeutics Inc. [FOLD]. What else is Wall St. saying

Caleb Clifford July 1, 2021

Industry

Wall Street Analyst Initiated Amicus Therapeutics Inc. [FOLD]. What else is Wall St. saying

Misty Lee June 25, 2021

Finance

Amicus Therapeutics Inc. [FOLD] fell -61.02% so far this year. What now?

Misty Lee May 27, 2021

Finance

Amicus Therapeutics Inc. [FOLD] Revenue clocked in at $260.90 million, down -56.78% YTD: What’s Next?

Edison Baldwin April 15, 2021

Finance

Market Analysts see Amicus Therapeutics Inc. [FOLD] gaining to $13. Time to buy?

Annabelle Farmer March 26, 2021

Market

Amicus Therapeutics Inc. [FOLD] moved down -4.29: Why It’s Important

Misty Lee February 12, 2021

« Previous Page1 Page2 Next »

Company

HomePage
About US
Our Team
Contact US
STOCK STORIES

Categories

Companies
Equity Analysis
Finance
Market
Stock Stories

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Email

© DBT NEWS. All rights reserved.

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam

About Us
Contact Us
Homepage
Our Team
Thank You